Philadelphia [USA], June 13 (ANI): In a breakthrough study, a team of cancer researchers have implied a strategy using the tools used for the development of cancer immunotherapies and adapted them to identify the 'right protein sequences to target in SARS-CoV-2,' the virus that causes cor